Miles Capital’s Repligen RGEN Stock Holding History

Miles Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,832	Closed	-$406K	–	185
2015 Q2	$406K	Sell	9,832 -848	-8%	-$31.1K	0.27%	100
2015 Q1	$324K	Buy	+10,680	New	+$277K	0.19%	121

Other funds holding RGEN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Miles Capital's RGEN Position: Q3 2015 in Review

Miles Capital sold out of Repligen (RGEN) in Q3 2015, closing a stake of 9,832 shares — an estimated $406K sold.

Miles Capital first reported a position in RGEN in Q1 2015 and held it in 2 quarters. The position peaked at $406K in Q2 2015. 184 funds tracked by Wall St. Rank hold RGEN as of Q3 2015.

Miles Capital reported no remaining Repligen position as of Q3 2015 after selling out during the quarter.
Miles Capital sold 9,832 Repligen shares in Q3 2015, an estimated $406K.
Miles Capital first reported a position in Repligen in Q1 2015 and held it in 2 quarters.
Miles Capital's Repligen position peaked at $406K in Q2 2015.
184 funds tracked by Wall St. Rank held Repligen as of Q3 2015.

Based on Miles Capital's 13F filing for Q3 2015, filed 27 Oct 2015.